Close
Help




JOURNAL

Drug Target Insights

Drug Target Exploitable Structural Features of Adenylyl Cyclase Activity in Schistosoma mansoni

Submit a Paper


Drug Target Insights 2012:6 41-58

Original Research

Published on 24 Oct 2012

DOI: 10.4137/DTI.S10219


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Drug Target Insights

Abstract

The draft genome sequence of the parasitic flatworm Schistosoma mansoni (S. mansoni), a cause of schistosomiasis, encodes a predicted guanosine triphosphate (GTP) binding protein tagged Smp_059340.1. Smp_059340.1 is predicted to be a member of the G protein alpha-s subunit responsible for regulating adenylyl cyclase activity in S. mansoni and a possible drug target against the parasite. Our structural bioinformatics analyses identified key amino acid residues (Ser53, Thr188, Asp207 and Gly210) in the two molecular switches responsible for cycling the protein between active (GTP bound) and inactive (GDP bound) states. Residue Thr188 is located on Switch I region while Gly210 is located on Switch II region with Switch II longer than Switch I. The Asp207 is located on the G3 box motif and Ser53 is the binding residue for magnesium ion. These findings offer new insights into the dynamic and functional determinants of the Smp_059340.1 protein in regulating the S. mansoni life cycle. The binding interfaces and their residues could be used as starting points for selective modulations of interactions within the pathway using small molecules, peptides or mutagenesis.



Downloads

PDF  (3.51 MB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML

PMC HTML


Sharing


What Your Colleagues Say About Drug Target Insights
I have had contact with Drug Target Insights several times, and every time I am impressed by the handling of the manuscript. The website is very, very user-friendly. It is easy to submit a manuscript.  The entire process is easy and straightforward.  The corresponding author is kept updated on the progress at every point.  The editors of Libertas were helpful and prompt in responding to questions and issues related to the submission I am pleased ...
Dr Bodil Ohlsson (Lund University, Sweden)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube